VivekMurthyMD
Pulmonology • New York, NYInterventional Pulmonology, Pleural Disease, Thoracic Oncology
Assistant Professor of Medicine and Cardiothoracic Surgery, NYU Grossman School of Medicine
Dr. Murthy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 1st Ave
New York, NY 10016Phone+1 212-731-6070
Summary
- Dr. Vivek Murthy is a pulmonologist based in New York, NY, focusing on interventional pulmonology, bronchoscopy, pleural disease and thoracic oncology. He completed his fellowship in Pulmonary Disease and Critical Care Medicine at NYU Grossman School of Medicine in 2017, followed by subspecialty fellowship training in Interventional Pulmonology at NYU.
Currently, he serves as:
- Program Director, Interventional Pulmonology fellowship program at NYU Grossman School of Medicine.
- Associate Director of Interventional Pulmonology and Bronchoscopy at NYU Langone Hospital
- Site Director of Interventional Pulmonology at Bellevue Hospital
- Director of Lung Cancer Screening at Bellevue Hospital Center
Education & Training
NYU Grossman School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2014 - 2018
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2011 - 2014
Stony Brook University Health Sciences Center School of MedicineClass of 2011
Certifications & Licensure
NY State Medical License 2015 - 2026
OH State Medical License 2011 - 2014
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
American Association for Bronchology and Interventional PulmonologyDiplomate, Interventional Pulmonology
Publications & Presentations
PubMed
- 4 citationsPleural fluid microbiota as a biomarker for malignancy and prognosis.Benjamin Kwok, Benjamin G Wu, Ibrahim F Kocak, Imran Sulaiman, Rosemary Schluger
Scientific Reports. 2023-02-08 - 4 citationsImmunotherapy for mesothelioma: Moving beyond single immune check point inhibition.Luca Cantini, Isaac Laniado, Vivek Murthy, Daniel Sterman, Joachim G J V Aerts
Lung Cancer. 2022-03-01 - 9 citationsTumor-draining lymph nodes demonstrate a suppressive immunophenotype in patients with non-small cell lung cancer assessed by endobronchial ultrasound-guided transbronc...Vivek Murthy, Daniel Katzman, Jun Chieh J. Tsay, Jamie L. Bessich, Gaetane Michaud
Lung Cancer. 2019-08-13
Journal Articles
- Airway Microbiota Is Associated with up-Regulation of the PI3K Pathway in Lung CancerBenjamin G Wu, Harvey Pass, William N Rom, Daniel H Sterman, Vivek Murthy, Martin J Blaser, Michael D Weiden, Leopoldo N Segal, ATS Journals
Press Mentions
Alcohol and Cancer Risk: Murthy’s Parting Call for Warning LabelsFebruary 19th, 2025- Alcohol Poses These 8 Risks to Older Adults, Experts WarnJanuary 25th, 2025
- How Much Alcohol Is Safe to Drink Without Putting Your Health at Risk?January 18th, 2025
- Join now to see all
Research History
- Fellow, NYU Pulmonary Oncology Research TeamNYU PORT engages in translational research on diagnostic (biomarkers, tumor immunology) and therapeutic approaches to lung cancer and mesothelioma.2016 - Present
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
